HEMISPHERX BIOPHARMA, INC

Inactive Instrument

Transcripts Hemispherx BioPharma, Inc Nyse

Equities

US42366C1036

End-of-day quote Nyse Other stock markets
- ^USD	-

Apr. 10	AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer	CI
Apr. 02	Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024	Apr. 02
Transcript : AIM ImmunoTech Inc. - Special Call	Mar. 20
Transcript : AIM ImmunoTech Inc. - Pre Recorded Special Call	Jan. 09
Transcript : AIM ImmunoTech Inc., Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
Transcript : AIM ImmunoTech Inc., Q2 2023 Earnings Call, Aug 15, 2023	23-08-15
Transcript : Hemispherx Biopharma, Inc., Q2 2017 Earnings Call, Aug 15, 2017	17-08-15
Transcript : Hemispherx Biopharma, Inc., 2016 Earnings Call, Apr 07, 2017	17-04-07
Transcript : Hemispherx Biopharma, Inc., Q3 2016 Earnings Call, Nov 15, 2016	16-11-15
Transcript : Hemispherx Biopharma, Inc., Q2 2016 Earnings Call, Aug 19, 2016	16-08-19
Transcript : Hemispherx Biopharma, Inc., Q1 2016 Earnings Call, May 17, 2016	16-05-17
Transcript : Hemispherx Biopharma, Inc., 2015 Earnings Call, Mar 30, 2016	16-03-30
Transcript : Hemispherx Biopharma, Inc., 2011 Earnings Call, Mar 22, 2012	12-03-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer